Incidence of Adverse Drug Reactions in Hospitalized Patients

OBJECTIVE To estimate the incidence of serious and fatal adverse drug reactions (ADR) in hospital patients. DATA SOURCES Four electronic databases were searched from 1966 to 1996. STUDY SELECTION Of 153, we selected 39 prospective studies from US hospitals. DATA EXTRACTION Data extracted independently by 2 investigators were analyzed by a random-effects model. To obtain the overall incidence of ADRs in hospitalized patients, we combined the incidence of ADRs occurring while in the hospital plus the incidence of ADRs causing admission to hospital. We excluded errors in drug administration, noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs. Serious ADRs were defined as those that required hospitalization, were permanently disabling, or resulted in death. DATA SYNTHESIS The overall incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We estimated that in 1994 overall 2216000 (1721000-2711000) hospitalized patients had serious ADRs and 106000 (76000-137000) had fatal ADRs, making these reactions between the fourth and sixth leading cause of death. CONCLUSIONS The incidence of serious and fatal ADRs in US hospitals was found to be extremely high. While our results must be viewed with circumspection because of heterogeneity among studies and small biases in the samples, these data nevertheless suggest that ADRs represent an important clinical issue.

[1]  E. Schimmel.  The hazards of hospitalization* , 2003, Annals of internal medicine.

[2]  HOSPITALIZATION OF CHILDREN. , 1964, Pediatrics.

[3]  L. Cluff,et al.  STUDIES ON THE EPIDEMIOLOGY OF ADVERSE DRUG REACTIONS. I. METHODS OF SURVEILLANCE. , 1964, JAMA.

[4]  W. Reichel.  COMPLICATIONS IN THE CARE OF FIVE HUNDRED ELDERLY HOSPITALIZED PATIENTS * , 1965, Journal of the American Geriatrics Society.

[5]  L. Cluff,et al.  Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. , 1966, Annals of internal medicine.

[6]  G O Barnett,et al.  Drug utilization and adverse reactions in a general hospital. , 1967, Hospitals.

[7]  R. Ogilvie,et al.  Adverse drug reactions during hospitalization. , 1967, Canadian Medical Association journal.

[8]  H. Jick,et al.  Assessment of adverse reactions within a drug surveillance program. , 1968, JAMA.

[9]  N Hurwitz,et al.  Intensive Hospital Monitoring of Adverse Reactions to Drugs , 1969, British medical journal.

[10]  N Hurwitz,et al.  Predisposing Factors in Adverse Reactions to Drugs , 1969, British medical journal.

[11]  Pierce Gardner,et al.  Adverse drug reactions: A pharmacist‐based monitoring system , 1970, Clinical pharmacology and therapeutics.

[12]  R. Stewart,et al.  Studies on the epidemiology of adverse drug reactions. VI. Utilization and interactions of prescription and nonprescription drugs in outpatients. , 1971, The Johns Hopkins medical journal.

[13]  L. C. Terry,et al.  Adverse drug reactions in a veterans administration hospital. , 1971, The Journal of clinical pharmacology and new drugs.

[14]  Mcqueen Eg,et al.  Adverse reactions to drugs: a comprehensive hospital inpatient survey. , 1972 .

[15]  E. Mcqueen,et al.  Adverse reactions to drugs: a comprehensive hospital inpatient survey. , 1972, The New Zealand medical journal.

[16]  R. Miller.  Drug surveillance utilizing epidemiologic methods. A report from the Boston Collaborative Drug Surveillance Program. , 1973, American journal of hospital pharmacy.

[17]  R. Stewart,et al.  A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. , 1973, American journal of hospital pharmacy.

[18]  E. Mcqueen,et al.  Adverse drug reactions in a general hospital. , 1973, The New Zealand medical journal.

[19]  Adverse drug reactions in a general hospital. , 1973 .

[20]  R R Miller,et al.  Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program. , 1974, Archives of internal medicine.

[21]  R. Stewart,et al.  Drug-induced illness leading to hospitalization. , 1974, JAMA.

[22]  L Lasagna,et al.  Adverse drug reactions. A critical review. , 1975, JAMA.

[23]  L Lasagna,et al.  Adverse drug reactions—a matter of opinion , 1976, Clinical pharmacology and therapeutics.

[24]  S. R. Fine,et al.  ADVERSE DRUG REACTIONS , 2009, BMJ : British Medical Journal.

[25]  L. Cluff,et al.  Adverse drug reactions leading to hospitalization in children. , 1976, The Journal of pediatrics.

[26]  F. E. May,et al.  Drug use and adverse drug reactions prior to and during hospitalization. , 1977, Journal of the American Pharmaceutical Association.

[27]  A G Lipman,et al.  Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. , 1977, American journal of hospital pharmacy.

[28]  J. Cooper,et al.  Community-hospital pharmacist detection of drug-related problems upon patient admission to small hospitals. , 1977, American journal of hospital pharmacy.

[29]  S. Shapiro,et al.  Drug utilization and reported adverse reactions in hospitalized children. , 1979, American journal of epidemiology.

[30]  J. E. Adams,et al.  Drug-related admissions to an inpatient psychiatric unit. , 1980, The American journal of psychiatry.

[31]  C. Naranjo,et al.  Sex-related variations in the frequency and characteristics of adverse drug reactions. , 1980, International journal of clinical pharmacology, therapy, and toxicology.

[32]  P M Gertman,et al.  Iatrogenic illness on a general medical service at a university hospital* , 1981, Quality and Safety in Health Care.

[33]  T C Chalmers,et al.  A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.

[34]  Bernard R. Rosner,et al.  Fundamentals of Biostatistics. , 1992 .

[35]  T. Keane,et al.  Drug-Related Admissions to a Veterans' Administration Psychiatric Unit , 1984, Drug intelligence & clinical pharmacy.

[36]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[37]  D. Breslau,et al.  Hospital admissions caused by iatrogenic disease. , 1986, Archives of internal medicine.

[38]  I. Ruiz,et al.  Influence of the assessment of the severity on the frequency of adverse drug reactions (ADRs). , 1987, International journal of clinical pharmacology, therapy, and toxicology.

[39]  A. Komaroff,et al.  Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility. , 1987, The American journal of medicine.

[40]  S. Shapiro,et al.  Adverse drug reactions in children leading to hospital admission. , 1988, Pediatrics.

[41]  E. Keeler,et al.  The effects of the DRG-based prospective payment system on quality of care for hospitalized Medicare patients. An introduction to the series. , 1990, JAMA.

[42]  N. Col,et al.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.

[43]  Roberto Bernabei,et al.  Is Age an Independent Risk Factor of Adverse Drug Reactions in Hospitalized Medical Patients?* , 1991, Journal of the American Geriatrics Society.

[44]  Graves Ej,et al.  National hospital discharge survey. , 1994, Vital and health statistics. Series 13, Data from the National Health Survey.

[45]  T R Einarson,et al.  Drug-Related Hospital Admissions , 1993, The Annals of pharmacotherapy.

[46]  L. Bowman,et al.  Incidence of adverse drug reactions in adult medical inpatients. , 1994, The Canadian journal of hospital pharmacy.

[47]  R S Evans,et al.  Preventing Adverse Drug Events in Hospitalized Patients , 1994, The Annals of pharmacotherapy.

[48]  J. Griffin,et al.  Thalidomide revisited. , 1994, Adverse drug reactions and toxicological reviews.

[49]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[50]  G A Colditz,et al.  Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. , 1995, American journal of epidemiology.

[51]  C S Berkey,et al.  A random-effects regression model for meta-analysis. , 1995, Statistics in medicine.

[52]  R. Talbert,et al.  Drug‐Related Hospital Admissions , 1996, Pharmacotherapy.

[53]  S. Morgan,et al.  Health Care State Rankings 1995 , 1996 .

[54]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[55]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.

[56]  B T Collopy.  Reporting of adverse events in hospitals in Victoria 1994‐1995 , 1997, The Medical journal of Australia.